High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Gonesse
About this trial
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.
Eligibility criteria
Qualifiers
Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan.
Follow-up CT scan performed within 24 to 48 hours.
Absence of initial contrast-enhanced CT or follow-up CT.
Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH).
Disqualifiers
Patient deceased before the initial contrast-enhanced CT.
Major missing clinical data.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 4 trial groupsSponsors and collaborators
Source ClinicalTrials.gov